2026 GI Board Review and Best Practices Course

August 29, 2026 to August 31, 2026
The William M. Steinberg Board Review in Gastroenterology and Best Practices Course is designed for fellows, and post- fellowship physicians preparing to take their Certifying or Recertifying board exam and/ or for those who desire a comprehensive review and current update of gastroenterology. In addition, nurse practitioners and physician assistants working in a GI practice will find this course appropriate for their educational needs.
 
A faculty of expert clinicians from around the country will emphasize up-to-date information (including current national GI/hepatology society guidelines) supplemented with board –type questions. Audience participation is encouraged with the use of our new Audience Response System (ARS). The review will include information on the diagnosis and management of disorders of the esophagus, stomach, small and large intestine, pancreas, biliary tree and liver.

Target Audience

 

This accredited CE activity is designed for gastroenterologists and gastroenterology fellows.

Learning Objectives

At the conclusion of this activity, participants should be able to:
 
  • Apply current evidence‑based guidelines to support accurate diagnosis and effective management of gastrointestinal and hepatologic diseases.
  • Integrate patient‑specific clinical information with emerging research to guide appropriate diagnostic testing and therapeutic decision‑making.
  • Differentiate among common and complex gastrointestinal disease processes and select the most appropriate evaluation and management strategies.
  • Formulate evidence‑based treatment plans for acute and chronic GI conditions, including strategies for prevention, monitoring, and complication management.
  • Incorporate contemporary standards of care in the assessment and management of gastrointestinal malignancies and hereditary cancer syndromes.
  • Use clinical reasoning in case‑based scenarios to arrive at accurate diagnoses and implement appropriate, patient‑centered management plans.

Course summary

Available credit: 
  • 25.50 ABIM MOC 2
  • 25.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 25.50 Completion
Course opens: 
08/26/2026
Course expires: 
08/29/2029
Event starts: 
08/29/2026 - 8:00am EDT
Event ends: 
08/31/2026 - 7:00pm EDT
Add to calendar: 
Faculty & Disclosure

Course Director

William Steinberg, MD
President
Capital Academics, LLC
Clinical Professor of Medicine
George Washington University Medical Center

 

Faculty

Randall Brand MD
Professor of Medicine
University of Pittsburgh Medical Center
Pittsburgh, PA
 
Brooks Cash, MD
Professor of Medicine
Director, Functional Bowel Center
Baylor, Scott and White/ Baylor University Medical Center
Dallas, TX
                 
Francis M. Giardiello, MD            
Professor of Medicine, Oncology, and Pathology, Emeritus.
Johns Hopkins School of Medicine
Baltimore, MD
 
Phil A. Hart, MD
Professor of Medicine
Division of Gastroenterology, Hepatology and Nutrition
The Ohio State University Wexner Medical Center
Columbus, OH
 
Colin Howden, MD
Professor Emeritus,
Department of Medicine,
University of Tennessee College of Medicine,
Memphis, TN
 
Karen Krok, MD
Professor of Medicine
Medical Director, Liver Transplant Program
Penn State Hershey Medical Center
Hershey, PA    
 
Gerard Mullin, MD
Associate Professor of Medicine
Johns Hopkins University Medical Center
Baltimore, MD
 
Satish Rao, MD, PhD
Professor of Medicine
J Harold Harrison, Distinguished University Chair in Gastroenterology
Medical College of Georgia
Augusta University     
Augusta, GA
        
David T. Rubin, MD
Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
 
Mark W. Russo, MD, MPH
Chief, Hepatology
Medical Director of Liver Transplantation
Atrium Health Wake Forest
Professor of Medicine
Wake Forest School of Medicine, Charlotte Campus
Charlotte, NC
 
Lawrence Schiller, MD
Clinical Professor, Department of Medical Education
Texas A&M University College of Medicine, Dallas Campus
Chair, Institutional Review Boards for Human Subject Protection
Baylor Scott and White Research Institute
Dallas, TX
 
Mitchell Shiffman, MD
Director, Liver Institute of Virginia
Bon Secours Mercy Health System
Richmond and Newport News, VA                    
Professor of Medicine
Eastern Virginia Medical School
Norfolk, VA
 
Stuart Spechler, MD
Chief, Division of Gastroenterology,
Co-Director, Center for Esophageal Diseases
Baylor University Medical Center Dallas
Investigator/Professor, Co-Director, Center for Esophageal Research
Baylor Scott and White Research Institute
Dallas, Texas
 
Arnold Wald, MD                        
Professor of Medicine
Division of Gastroenterology and Hepatology
University of Wisconsin School of Medicine and Public Health
Madison, WI 

 

Staff

Rob Betz
Cathy Wesler
Leticia Foote
Naomi Loughlin
 
Disclosure of Financial Relationships
In accordance with the Standards for Integrity and Independence, GW requires all planners, faculty, and others in a position to control the educational content of an accredited CE activity to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months.
 
An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE activity. An individual is considered to have a relevant financial relationship if the educational content they can control is related to the business lines or products of the ineligible company.
 
Disclosure Statement(s)
Absence of Relevant Financial Relationships
The following planners, faculty, staff, and others in a position to control the content of this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.
 
Faculty & Planners
 
William Steinberg, MD (Course Director)
Francis M. Giardiello, MD
Gerard Mullin, MD
Lawrence R. Schiller, MD
Mark Russo, MD
Satish Rao, MD
Arnold Wald, MD
 
Staff
 
Rob Betz
Cathy Wesler
Leticia Foote
Naomi Loughlin
 
Relevant Financial Relationships
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following individuals in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
All relevant financial relationships listed for these individual(s) have been mitigated.
 
Randall Brand, MD
  • Advisor/consultant: ClearNote Health, Immunovia
 
Brooks D. Cash, MD
  • Advisor/consultant: AbbVie, Alnylam, Ardelyx, Phathom, QOL Medical Researcher and speaker: AbbVie, Alnylam, Ardelyx, Phathom, QOL Medical
 
Philip Hart, MD
  • Advisor/consultant: Amgen, Sanofi, Zenas Biopharma
 
Colin William Howden, MD
  • Advisor/consultant: Phathom, RedHill Biopharma, Sebela Chair, Data and Safety Monitoring Board: AQUA Medical, ISOThrive
 
Karen Krok, MD
  • Advisor/consultant: Gilead, Ipsen
 
David T. Rubin, MD
  • Consultant: AbbVie, Abivax SA, Altrubio, Boehringer/Ingelheim, Bristol-Myers Squibb, Cabletta Bio, Celltrion, EcoR1 Capital, Eli Lilly & Co., Ensho Therapeutics, Genentech (Roche), Gilead Sciences, Iterative Health, Johnson & Johnson, Merck & Co., Mirador Therapeutics, Palisade Bio, Pfizer, Sanofi, Spyre, Takeda Pharmaceuticals, Throne, Tr1X, Xencor
  • Research funding: Takeda
 
Mitchell L. Shiffman, MD
  • Advisor/consultant: 89 Bio, Akero, Altimmune, Atea, Camarus, Exact Sciences, Hamni, Inventiva, Pliant Researcher: Fujifilm, Genentech, Gilead, Intra-Sana, Ipsen, Madrigal, Mirum, Novo Nordisk
 
Stuart Spechler, MD
  • Consultant: AnaptysBio, Castle Biosciences, Cyted Health, Lucid Diagnostics, Phathom Pharmaceuticals
 
Disclaimer
The information in this accredited CE activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this accredited CE activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
 
Acknowledgement of Commercial Support
No commercial support was received for this accredited CE activity.

 

 

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and Capital Academics. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
 
Physicians (CME)
 
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 25.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Physicians (MOC)
 
Successful completion of this CME activity enables the participant to earn up to 25.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Healthcare Professionals (Attendance)
 
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance.  Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.

Available Credit

  • 25.50 ABIM MOC 2
  • 25.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 25.50 Completion
Please login or register to take this course.

 

Please note that you must be logged in to complete the CE credit claim process. 

New Users

You must create a learner account prior to claiming CE credit. 

Click here to create a learner account

Click here to access additional instructions for creating a learner account

Returning Users

Click here to login and proceed with claiming CE credit.